Actively Recruiting
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Led by Novartis Pharmaceuticals · Updated on 2026-04-13
500
Participants Needed
36
Research Sites
177 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to describe routine clinical practice with lutetium (177Lu) vipivotide tetraxetan on Health related quality of life (HRQoL) at baseline, on treatment, and post progression.
CONDITIONS
Official Title
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult male patients diagnosed with metastatic castration-resistant prostate cancer (mCRPC) and initiating lutetium (177Lu) vipivotide tetraxetan as prescribed by their physician
- Age 18 years or older at the time of enrollment
- Written informed consent obtained before any data collection
- Willing to participate in quality of life data collection for up to 1 year after treatment
You will not qualify if you...
- Participation in any investigational trial or another Novartis-sponsored non-interventional study involving lutetium (177Lu) vipivotide tetraxetan during the identification period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 36 locations
1
Novartis Investigative Site
Konstanz, Baden-Wurttemberg, Germany, 78464
Actively Recruiting
2
Novartis Investigative Site
Stuttgart, Baden-Wurttemberg, Germany, 70174
Actively Recruiting
3
Novartis Investigative Site
Munich, Bavaria, Germany, 81377
Actively Recruiting
4
Novartis Investigative Site
Regensburg, Bavaria, Germany, 93053
Actively Recruiting
5
Novartis Investigative Site
Würzburg, Bavaria, Germany, 97080
Actively Recruiting
6
Novartis Investigative Site
Cottbus, Brandenburg, Germany, 03048
Actively Recruiting
7
Novartis Investigative Site
Frankfurt (Oder), Brandenburg, Germany, 15236
Actively Recruiting
8
Novartis Investigative Site
Ludwigshafen, Germany, Germany, 67063
Actively Recruiting
9
Novartis Investigative Site
Marburg, Hesse, Germany, 35043
Actively Recruiting
10
Novartis Investigative Site
Cologne, North Rhine-Westphalia, Germany, 50937
Actively Recruiting
11
Novartis Investigative Site
Dresden, Saxony, Germany, 01307
Actively Recruiting
12
Novartis Investigative Site
Leipzig, Saxony, Germany, 04103
Actively Recruiting
13
Novartis Investigative Site
Halle, Saxony-Anhalt, Germany, 06120
Actively Recruiting
14
Novartis Investigative Site
Jena, Thuringia, Germany, 07740
Actively Recruiting
15
Novartis Investigative Site
Aachen, Germany, 52074
Actively Recruiting
16
Novartis Investigative Site
Augsburg, Germany, 86179
Actively Recruiting
17
Novartis Investigative Site
Berlin, Germany, 10249
Actively Recruiting
18
Novartis Investigative Site
Berlin, Germany, 12559
Actively Recruiting
19
Novartis Investigative Site
Berlin, Germany, 13125
Actively Recruiting
20
Novartis Investigative Site
Bielefeld, Germany, 33611
Actively Recruiting
21
Novartis Investigative Site
Bonn, Germany, 53105
Actively Recruiting
22
Novartis Investigative Site
Chemnitz, Germany, 09113
Actively Recruiting
23
Novartis Investigative Site
Dortmund, Germany, 44137
Actively Recruiting
24
Novartis Investigative Site
Dortmund, Germany, 44309
Actively Recruiting
25
Novartis Investigative Site
Erlangen, Germany, 91054
Actively Recruiting
26
Novartis Investigative Site
Essen, Germany, 45147
Actively Recruiting
27
Novartis Investigative Site
Fulda, Germany, 36043
Actively Recruiting
28
Novartis Investigative Site
Herford, Germany, 32049
Actively Recruiting
29
Novartis Investigative Site
Homburg, Germany, 66421
Actively Recruiting
30
Novartis Investigative Site
Magdeburg, Germany, 39120
Actively Recruiting
31
Novartis Investigative Site
Mainz, Germany, 55131
Actively Recruiting
32
Novartis Investigative Site
Nuremberg, Germany, 90419
Actively Recruiting
33
Novartis Investigative Site
Rostock, Germany, 18057
Actively Recruiting
34
Novartis Investigative Site
Trier, Germany, 54290
Actively Recruiting
35
Novartis Investigative Site
Tübingen, Germany, 72076
Actively Recruiting
36
Novartis Investigative Site
Ulm, Germany, 89081
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here